| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TSHR |
IPI00386365 |
10.080 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
10.080 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
GLRA1 |
IPI00011565 |
10.080 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
GABRB1 |
GABRB1: Gamma-aminobutyric acid receptor subunit beta-1 precursor |
10.080 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
HIST1H1C |
HIST1H1C, H1F2: Histone H1.2 |
10.080 |
Evidence |
|
| ITGB3 |
ITGB3, GP3A: Integrin beta-3 precursor |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
10.080 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
ATP2A2 |
ATP2A2, ATP2B: Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 |
10.080 |
Evidence |
|
| SNAP23 |
SNAP23: Synaptosomal-associated protein 23 |
PSMC1 |
PSMC1: 26S protease regulatory subunit 4 |
10.080 |
Evidence |
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
TMSB4X |
TMSB4X, TB4X, THYB4, TMSB4: Thymosin beta-4 |
10.070 |
Evidence |
|
| CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
PROC |
PROC: Vitamin K-dependent protein C precursor |
10.060 |
Evidence |
|
| LYN |
LYN: Tyrosine-protein kinase Lyn |
ACTN1 |
ACTN1: Alpha-actinin-1 |
10.060 |
Evidence |
|
| CCNL1 |
CCNL1, BM-001, UNQ530/PRO1073: Cyclin-L1 |
CCNB1 |
Cyclin B1 |
10.060 |
Evidence |
|
| CAMK1 |
CAMK1: Calcium/calmodulin-dependent protein kinase type 1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
10.060 |
Evidence |
|
| DAB2 |
DAB2, DOC2: Disabled homolog 2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
10.060 |
Evidence |
|
| YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
10.060 |
Evidence |
|
| MAPK12 |
MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
10.060 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
10.060 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
MAP2K6 |
MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki |
10.060 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
CDK5 |
CDK5: Cell division protein kinase 5 |
10.060 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
MAPK12 |
MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 |
10.060 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
MAP2K6 |
MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki |
10.060 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
DNMBP |
DNMBP, KIAA1010: Dynamin-binding protein |
10.060 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
10.060 |
Evidence |
|
| WEE1 |
WEE1: Wee1-like protein kinase |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
10.060 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
ARHGAP12 |
ARHGAP12: Rho GTPase-activating protein 12 |
10.060 |
Evidence |
|